Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy
Irene Gage(Johns Hopkins University), James L. Connolly(Beth Israel Deaconess Medical Center), Abram Recht(Beth Israel Deaconess Medical Center), Timothy J. Eberlein, Stuart J. Schnitt(Brigham and Women's Hospital), Susan L. Troyan(Harvard University Press), Susan M. Love(University of California, Los Angeles), Asa J. Nixon(Dana-Farber Brigham Cancer Center), Jay R. Harris(Harvard University), Rebecca Gelman(Dana-Farber Cancer Institute), Barbara Silver(Brigham and Women's Hospital)
Cited by 330
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k